Press release
21-Nov-2017

At Pharmaceutical Serialization & Traceability Summit 2017, Adents to Address Aspects of Comprehensive Level 4 Solutions

Pavel Lotkov, Director of Product Management, to Present Enterprise-level Track & Trace Concepts at Vienna-based Conference.

Adents, a leading provider of premier versatile serialization and track-and-trace solutions, will deliver a presentation on November 29 addressing the components needed to achieve a comprehensive Level 4 cloud serialization and traceability solution at the Pharmaceutical Serialization & Traceability Summit 2017, November 27-29 at the Vienna Marriott Hotel. Titled “How to Ensure Reliable and Seamless Management, Sharing and Reporting of Serialization Data”, the presentation will be given by Pavel Lotkov, Director of Product Management.

With EU FMD serialization deadlines approaching in February 2019, and enforcement of the US DSCSA scheduled for November 2018, comprehensive serialization efforts are in full swing on both sides of the Atlantic. With the timeframe dwindling for ensuring sufficient infrastructure at the enterprise level and throughout the supply chain, far-reaching Level 4 systems are uniquely positioned to deliver mandatory data sharing at various touchpoints.

Part of Mr. Lotkov’s discussion will focus on Adents Prodigi, the company’s signature Cloud-based Level 4 solution. Adents Prodigi centrally manages regulatory requirements mandated in the pharmaceutical industry, allowing pharmaceutical companies and CMOs to take advantage of the massive amounts of data generated during the serialization and track & trace process. In addition to offering compliance with incrementally complex regulations, Adents Prodigi opens up new horizons beyond regulatory compliance in terms of data analysis, machine learning tools and additional capabilities through third party solutions.

Adents Prodigi also offers a certified gateway to the European Hub, having passed a series of thorough tests with the European Medicines Verification Organization. Per the EU FMD, reporting to the European Hub will entail generating and managing serialization data compliant with each target market. The certification makes Adents an official On-Boarding Partner Gateway Provider (OBP) authorized to sign on behalf of Marketing Authorization Holders and transfer their unique identifiers and related information to the European Hub. In essence, Adents can now legally vouch for its customers concerning serialization compliance.

Adents has acquired a reputation for solutions enabling customers to comply with current and future serialization mandates with unsurpassed speed, limited machine downtime and minimal investment in new equipment or infrastructure.

“While extensive amounts of time and resources have been expended on line-site implementations, it is now critical to connect the dots with sufficient infrastructure both at the enterprise level and along the ensuing supply chain,” said Christophe Devins, CEO of Adents. “An urgent need exists for solutions capable of addressing the evolutionary nature of regulatory requirements as well as utilizing this data for metrics-driven business operation improvements.”

CONTACT
Christopher DALE
+1 (973) 227-8080 ext. 116
cdale@turchette.com

LATEST PRESS RELEASES

Rechon Life Science AB addresses new and future market regulations with Adents serialization solution to guarantee DSCSA and EU FMD compliance
Swedish-based pharmaceutical CDMO chose Adents Seriza solution to easily exchange serialization data with supply chain partners and gain new market shares
26-Mar
2019
READ MORE
Adents Prodigi Serialisation Solution Chosen by French Pharma Company to Ensure Compliance with EU Falsified Medicines Directive
Cloud Solution Enables Cristers to Easily Exchange Serialisation Data with Supply Chain Partners and Move Beyond Compliance to Improve Business Practices
06-Dec
2018
READ MORE
Adents to Present on Tokenizing Traceability Data at Malta Blockchain Summit
Adents to Present on Tokenizing Traceability Data at Malta Blockchain Summit
25-Oct
2018
READ MORE